Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr;7(1):141-150.
doi: 10.15171/apb.2017.018. Epub 2017 Apr 13.

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

Affiliations

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

Omid Zarei et al. Adv Pharm Bull. 2017 Apr.

Abstract

Purpose: Implication of protein-protein interactions (PPIs) in development of many diseases such as cancer makes them attractive for therapeutic intervention and rational drug design. RON (Recepteur d'Origine Nantais) tyrosine kinase receptor has gained considerable attention as promising target in cancer therapy. The activation of RON via its ligand, macrophage stimulation protein (MSP) is the most common mechanism of activation for this receptor. The aim of the current study was to perform in silico alanine scanning mutagenesis and to calculate binding energy for prediction of hot spots in protein-protein interface between RON and MSPβ chain (MSPβ). Methods: In this work the residues at the interface of RON-MSPβ complex were mutated to alanine and then molecular dynamics simulation was used to calculate binding free energy. Results: The results revealed that Gln193, Arg220, Glu287, Pro288, Glu289, and His424 residues from RON and Arg521, His528, Ser565, Glu658, and Arg683 from MSPβ may play important roles in protein-protein interaction between RON and MSP. Conclusion: Identification of these RON hot spots is important in designing anti-RON drugs when the aim is to disrupt RON-MSP interaction. In the same way, the acquired information regarding the critical amino acids of MSPβ can be used in the process of rational drug design for developing MSP antagonizing agents, the development of novel MSP mimicking peptides where inhibition of RON activation is required, and the design of experimental site directed mutagenesis studies.

Keywords: Alanine screening; Cancer; Drug design; MSP; Molecular dynamic simulation; RON.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2

References

    1. Ngounou Wetie AG, Sokolowska I, Woods AG, Roy U, Loo JA, Darie CC. Investigation of stable and transient protein-protein interactions: Past, present, and future. Proteomics. 2013;13(3-4):538–57. doi: 10.1002/pmic.201200328. - DOI - PMC - PubMed
    1. Ryan DP, Matthews JM. Protein-protein interactions in human disease. Curr Opin Struct Biol. 2005;15(4):441–6. doi: 10.1016/j.sbi.2005.06.001. - DOI - PubMed
    1. Gonzalez MW, Kann MG. Chapter 4: Protein interactions and disease. PLoS Comput Biol. 2012;8(12):e1002819. doi: 10.1371/journal.pcbi.1002819. - DOI - PMC - PubMed
    1. Lage K. Protein-protein interactions and genetic diseases: The interactome. Biochim Biophys Acta. 2014;1842(10):1971–80. doi: 10.1016/j.bbadis.2014.05.028. - DOI - PMC - PubMed
    1. Ivanov AA, Khuri FR, Fu H. Targeting protein-protein interactions as an anticancer strategy. Trends Pharmacol Sci. 2013;34(7):393–400. doi: 10.1016/j.tips.2013.04.007. - DOI - PMC - PubMed

LinkOut - more resources